AlphaQuest LLC Raises Stock Position in Enhabit, Inc. (NYSE:EHAB)

AlphaQuest LLC raised its stake in shares of Enhabit, Inc. (NYSE:EHAB) by 106.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 33,310 shares of the company’s stock after buying an additional 17,166 shares during the period. AlphaQuest LLC’s holdings in Enhabit were worth $260,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of EHAB. Systematic Financial Management LP increased its position in Enhabit by 12.2% during the third quarter. Systematic Financial Management LP now owns 1,838,199 shares of the company’s stock valued at $14,522,000 after acquiring an additional 199,235 shares during the last quarter. Paradice Investment Management LLC lifted its stake in shares of Enhabit by 12.8% in the 4th quarter. Paradice Investment Management LLC now owns 1,780,113 shares of the company’s stock worth $13,903,000 after purchasing an additional 201,997 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Enhabit by 0.9% in the third quarter. Geode Capital Management LLC now owns 1,137,458 shares of the company’s stock worth $8,987,000 after buying an additional 10,538 shares during the last quarter. Jane Street Group LLC increased its holdings in Enhabit by 514.3% during the third quarter. Jane Street Group LLC now owns 901,084 shares of the company’s stock valued at $7,119,000 after buying an additional 754,395 shares during the last quarter. Finally, JPMorgan Chase & Co. raised its position in Enhabit by 37.8% in the third quarter. JPMorgan Chase & Co. now owns 305,245 shares of the company’s stock worth $2,411,000 after acquiring an additional 83,707 shares during the period.

Enhabit Trading Up 0.8 %

Shares of Enhabit stock opened at $8.58 on Friday. Enhabit, Inc. has a fifty-two week low of $6.85 and a fifty-two week high of $11.74. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46. The company has a market capitalization of $432.87 million, a P/E ratio of -3.70 and a beta of 1.80. The company has a fifty day moving average of $8.28 and a 200 day moving average of $7.92.

Wall Street Analyst Weigh In

EHAB has been the topic of a number of recent research reports. Jefferies Financial Group reaffirmed a “buy” rating on shares of Enhabit in a report on Thursday, March 6th. Leerink Partners reaffirmed a “market perform” rating and set a $8.00 price objective (down from $8.50) on shares of Enhabit in a research report on Tuesday, November 19th.

Enhabit Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.